Universal evaluation of MLC models in treatment planning systems based on a common set of dynamic tests.


Journal

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
ISSN: 1879-0887
Titre abrégé: Radiother Oncol
Pays: Ireland
ID NLM: 8407192

Informations de publication

Date de publication:
09 2023
Historique:
received: 29 01 2023
revised: 19 06 2023
accepted: 23 06 2023
medline: 21 8 2023
pubmed: 30 6 2023
entrez: 29 6 2023
Statut: ppublish

Résumé

To demonstrate the feasibility of characterising MLCs and MLC models implemented in TPSs using a common set of dynamic beams. A set of tests containing synchronous (SG) and asynchronous sweeping gaps (aSG) was distributed among twenty-five participating centres. Doses were measured with a Farmer-type ion chamber and computed in TPSs, which provided a dosimetric characterisation of the leaf tip, tongue-and-groove, and MLC transmission of each MLC, as well as an assessment of the MLC model in each TPS. Five MLC types and four TPSs were evaluated, covering the most frequent combinations used in radiotherapy departments. Measured differences within each MLC type were minimal, while large differences were found between MLC models implemented in clinical TPSs. This resulted in some concerning discrepancies, especially for the HD120 and Agility MLCs, for which differences between measured and calculated doses for some MLC-TPS combinations exceeded 10%. These large differences were particularly evident for small gap sizes (5 and 10 mm), as well as for larger gaps in the presence of tongue-and-groove effects. A much better agreement was found for the Millennium120 and Halcyon MLCs, differences being within ± 5% and ± 2.5%, respectively. The feasibility of using a common set of tests to assess MLC models in TPSs was demonstrated. Measurements within MLC types were very similar, but TPS dose calculations showed large variations. Standardisation of the MLC configuration in TPSs is necessary. The proposed procedure can be readily applied in radiotherapy departments and can be a valuable tool in IMRT and credentialing audits.

Identifiants

pubmed: 37385376
pii: S0167-8140(23)00313-4
doi: 10.1016/j.radonc.2023.109775
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

109775

Informations de copyright

Copyright © 2023 The Authors. Published by Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Jordi Saez (J)

Hospital Clínic de Barcelona, Department of Radiation Oncology, Barcelona, Spain. Electronic address: jordi.saez@gmail.com.

Raquel Bar-Deroma (R)

Rambam Health Care Campus, Department of Radiotherapy, Division of Oncology, Haifa, Israel.

Evelien Bogaert (E)

Ghent University Hospital and Ghent University, Department of Radiation Oncology, Ghent, Belgium.

Romain Cayez (R)

Oscar Lambret Center, Department of Medical Physics, Lille, France.

Tom Chow (T)

Juravinski Hospital and Cancer Centre at Hamilton Health Sciences, Department of Medical Physics, Ontario, Canada.

Catharine H Clark (CH)

National Physical Laboratory, Metrology for Medical Physics Centre, London TW11 0PX, UK; Radiotherapy Physics, University College London Hospital, 250 Euston Rd, London NW1 2PG, UK; Dept Medical Physics and Bioengineering, University College London, Malet Place, London WC1 6BT, UK.

Marco Esposito (M)

AUSL Toscana Centro, Medical Physics Unit, Florence, Italy; The Abdus Salam International Center for Theoretical, Trieste, Italy.

Vladimir Feygelman (V)

Moffitt Cancer Center, Department of Radiation Oncology, Tampa, FL, USA.

Angelo F Monti (AF)

ASST GOM Niguarda, Department of Medical Physics, Milano, Italy.

Julia Garcia-Miguel (J)

Consorci Sanitari de Terrassa, Department of Radiation Oncology, Terrassa, Spain.

Eduard Gershkevitsh (E)

North Estonia Medical Centre, Department of Medical Physics, Tallinn, Estonia.

Jo Goossens (J)

Iridium Netwerk, Department of Medical Physics, Antwerp, Belgium.

Carmen Herrero (C)

Centro Médico de Asturias-IMOMA, Department of Medical Physics, Oviedo, Spain.

Mohammad Hussein (M)

National Physical Laboratory, Metrology for Medical Physics Centre, London TW11 0PX, UK.

Catherine Khamphan (C)

Institut du Cancer - Avignon Provence, Department of Medical Physics, Avignon, France.

Roel G J Kierkels (RGJ)

Radiotherapiegroep, Department of Medical Physics, Arnhem/Deventer, the Netherlands.

Wolfgang Lechner (W)

Medical University of Vienna, Department of Radiation Oncology, Vienna, Austria.

Matthieu Lemire (M)

CIUSSS de l'Est-de-l'Île-de-Montréal, Service de Radio-Physique, Montréal, Canada.

Alexander Nevelsky (A)

Rambam Health Care Campus, Department of Radiotherapy, Division of Oncology, Haifa, Israel.

Daniel Nguyen (D)

Centre de Radiothérapie de Mâcon, France.

Lucia Paganini (L)

Humanitas Clinical and Research Center, Radiotherapy and Radiosurgery Department, Rozzano, Italy.

Marlies Pasler (M)

Lake Constance Radiation Oncology Center, Department of Radiation Oncology, Singen, Friedrichshafen, Germany; Radiotherapy Hirslanden, St. Gallen, Switzerland.

José Fernando Pérez Azorín (J)

Medical Physics and Radiation Protection Department, Gurutzeta-Cruces University Hospital, Barakaldo, Spain; Biocruces Health Research Institute, Barakaldo, Spain.

Luis Isaac Ramos Garcia (LI)

Servei de Radiofísica Hospitalària, Hospital Arnau de Vilanova, Lleida, Spain.

Serenella Russo (S)

AUSL Toscana Centro, Medical Physics Unit, Florence, Italy.

John Shakeshaft (J)

Gold Coast University Hospital, ICON Cancer Centre, Gold Coast, Australia.

Laure Vieillevigne (L)

Institut Claudius Regaud-Institut Universitaire du Cancer de Toulouse, Department of Medical Physics, Toulouse, France.

Victor Hernandez (V)

Hospital Sant Joan de Reus, Department of Medical Physics, Reus, Spain; Universitat Rovira i Virgili, Tarragona, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH